Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	2.04e-09	36	123	7	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	2.04e-09	36	123	7	GO:0015662
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.67e-09	11	123	5	GO:0005388
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.05e-07	62	123	7	GO:0019829
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCB4 ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	3.72e-07	109	123	8	GO:0042626
GeneOntologyMolecularFunction	calcium-dependent ATPase activity	ATP2A1 ATP2A3 ATP2B2	9.08e-07	4	123	3	GO:0030899
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ABCB4 ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.47e-05	178	123	8	GO:0015399
GeneOntologyMolecularFunction	P-type potassium:proton transporter activity	ATP12A ATP4A	1.12e-04	3	123	2	GO:0008900
GeneOntologyMolecularFunction	ATP hydrolysis activity	DHX36 DYNC2H1 ABCB4 ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	4.06e-04	441	123	10	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	DHX36 DYNC2H1 ZGRF1 ABCB4 MYO3B ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	4.13e-04	614	123	12	GO:0140657
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC26A2 SLCO6A1 ABCB4 ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	7.45e-04	477	123	10	GO:0022804
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	DHX36 DIRAS1 DYNC2H1 ABCB4 ENTPD3 ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A DIRAS2	9.90e-04	775	123	13	GO:0017111
GeneOntologyBiologicalProcess	regulation of cardiac conduction	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	7.97e-07	29	125	5	GO:1903779
GeneOntologyBiologicalProcess	cardiac conduction	FLNA ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.29e-05	100	125	6	GO:0061337
GeneOntologyBiologicalProcess	calcium ion transport from cytosol to endoplasmic reticulum	ATP2A2 ATP2A3	3.64e-05	2	125	2	GO:1903515
GeneOntologyBiologicalProcess	positive regulation of endoplasmic reticulum calcium ion concentration	ATP2A1 ATP2A2	1.09e-04	3	125	2	GO:0032470
GeneOntologyBiologicalProcess	plasma kallikrein-kinin cascade	PRCP KLKB1	1.09e-04	3	125	2	GO:0002353
GeneOntologyBiologicalProcess	positive regulation of activation of membrane attack complex	C3 C6	1.09e-04	3	125	2	GO:0001970
GeneOntologyCellularComponent	apical part of cell	DYNC2H1 SLC26A2 CUBN CEACAM1 CRB1 ABCB4 SHROOM4 CLCNKA AFDN ATP12A USH2A ATP2B2 ATP4A PDZD2	1.37e-05	592	126	14	GO:0045177
GeneOntologyCellularComponent	platelet dense tubular network membrane	ATP2A1 ATP2A2 ATP2A3	1.75e-05	9	126	3	GO:0031095
GeneOntologyCellularComponent	platelet dense tubular network	ATP2A1 ATP2A2 ATP2A3	3.41e-05	11	126	3	GO:0031094
GeneOntologyCellularComponent	H zone	DST ATP2A1	3.60e-05	2	126	2	GO:0031673
GeneOntologyCellularComponent	microvillus membrane	AMN1 SLC26A2 CUBN CEACAM1	7.93e-05	38	126	4	GO:0031528
GeneOntologyCellularComponent	potassium:proton exchanging ATPase complex	ATP12A ATP4A	1.08e-04	3	126	2	GO:0005889
GeneOntologyCellularComponent	apical plasma membrane	SLC26A2 CUBN CEACAM1 CRB1 ABCB4 SHROOM4 CLCNKA ATP12A USH2A ATP2B2 ATP4A	1.79e-04	487	126	11	GO:0016324
GeneOntologyCellularComponent	cell-cell junction	USP53 FLNA OBSCN CEACAM1 CRB1 ABCB4 SHROOM4 DST AMOT AFDN ATP2A2 PDZD2	2.43e-04	591	126	12	GO:0005911
GeneOntologyCellularComponent	side of membrane	CD244 SEMA7A CD177 CUBN CR1L CEACAM1 SHROOM4 CD4 DST ANTXR2 UMODL1 NEGR1 AMOT ATP2A2 FCMR	2.55e-04	875	126	15	GO:0098552
GeneOntologyCellularComponent	basal part of cell	CR1L SLCO6A1 CEACAM1 SHROOM4 DST CLCNKA PRCP ATP12A ATP2B2	4.82e-04	378	126	9	GO:0045178
GeneOntologyCellularComponent	actin filament bundle	FLNA ROR1 SHROOM4 DST AMOT	7.46e-04	118	126	5	GO:0032432
GeneOntologyCellularComponent	microvillus	AMN1 SLC26A2 CUBN CEACAM1 CRB1	9.00e-04	123	126	5	GO:0005902
GeneOntologyCellularComponent	cell surface	CD244 SEMA7A ROR1 CUBN CR1L CEACAM1 GHRHR DIP2A CD4 CD6 ANTXR2 UMODL1 MRC2 AMOT C3 FCMR	1.06e-03	1111	126	16	GO:0009986
GeneOntologyCellularComponent	external side of plasma membrane	CD244 SEMA7A CUBN CR1L CEACAM1 CD4 ANTXR2 UMODL1 AMOT FCMR	1.20e-03	519	126	10	GO:0009897
GeneOntologyCellularComponent	photoreceptor inner segment	CRB1 MYO3B CFAP418 USH2A	1.27e-03	78	126	4	GO:0001917
GeneOntologyCellularComponent	basal plasma membrane	CR1L SLCO6A1 CEACAM1 SHROOM4 DST CLCNKA ATP12A ATP2B2	1.39e-03	354	126	8	GO:0009925
GeneOntologyCellularComponent	actin-based cell projection	AMN1 SLC26A2 CUBN CEACAM1 CRB1 MYO3B USH2A	1.50e-03	278	126	7	GO:0098858
GeneOntologyCellularComponent	anchoring junction	USP53 FLNA OBSCN CEACAM1 CRB1 ABCB4 FOCAD SHROOM4 DST MRC2 AMOT AFDN ATP2A2 PDZD2	2.28e-03	976	126	14	GO:0070161
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	ATP2A1 ATP2A2 ATP2A3	2.52e-03	45	126	3	GO:0033017
GeneOntologyCellularComponent	cell-cell contact zone	OBSCN DST AFDN ATP2A2	2.53e-03	94	126	4	GO:0044291
GeneOntologyCellularComponent	apical junction complex	USP53 CRB1 SHROOM4 AMOT AFDN	2.71e-03	158	126	5	GO:0043296
GeneOntologyCellularComponent	receptor complex	FLNA RNMT ROR1 CUBN CR1L TNFRSF11B CEACAM1 CD4 CD6 PLXNB1	2.75e-03	581	126	10	GO:0043235
MousePheno	abnormal distortion product otoacoustic emission	USP53 ROR1 GRID1 TNFRSF11B USH2A ATP2B2	3.19e-05	85	100	6	MP:0004736
MousePheno	abnormal otoacoustic response	USP53 ROR1 GRID1 TNFRSF11B USH2A ATP2B2	3.41e-05	86	100	6	MP:0006336
MousePheno	increased food intake	ITPRID2 CEACAM1 SGK3 BRS3 BBS7 CLPS C3 VEGFD	6.20e-05	189	100	8	MP:0011939
Domain	ATPase_P-typ_TM_dom	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	5.52e-12	16	125	7	IPR023298
Domain	-	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	5.52e-12	16	125	7	1.20.1110.10
Domain	ATPase_P-typ_cation-transptr_C	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	9.34e-12	17	125	7	IPR006068
Domain	Cation_ATPase_C	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	9.34e-12	17	125	7	PF00689
Domain	Cation_ATPase_N	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.52e-11	18	125	7	PF00690
Domain	Cation_ATPase_N	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.52e-11	18	125	7	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	2.39e-11	19	125	7	IPR004014
Domain	ATPase_P-typ_cyto_domN	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	2.92e-09	35	125	7	IPR023299
Domain	Hydrolase_3	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.04e-09	10	125	5	PF08282
Domain	ATPase_P-typ_P_site	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	3.61e-09	36	125	7	IPR018303
Domain	P_typ_ATPase	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	3.61e-09	36	125	7	IPR001757
Domain	ATPASE_E1_E2	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	3.61e-09	36	125	7	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	4.42e-09	37	125	7	IPR008250
Domain	E1-E2_ATPase	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	4.42e-09	37	125	7	PF00122
Domain	-	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP4A	6.26e-08	32	125	6	3.40.1110.10
Domain	-	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP4A	6.26e-08	32	125	6	2.70.150.10
Domain	P-type_ATPase_IIA	ATP2A1 ATP2A2 ATP2A3	2.93e-07	3	125	3	IPR005782
Domain	HAD-like_dom	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	9.87e-07	79	125	7	IPR023214
Domain	ATP_Ca_trans_C	ATP2B2 ATP2B3	2.64e-04	4	125	2	IPR022141
Domain	ATP_Ca_trans_C	ATP2B2 ATP2B3	2.64e-04	4	125	2	PF12424
Domain	P-type_ATPase_IIB	ATP2B2 ATP2B3	2.64e-04	4	125	2	IPR006408
Domain	Sushi	CR1L SUSD5 C6 CSMD1	4.04e-04	52	125	4	PF00084
Domain	CCP	CR1L SUSD5 C6 CSMD1	4.67e-04	54	125	4	SM00032
Domain	LRR_6	AMN1 NLRP14 PHLPP1 FBXL2	5.01e-04	55	125	4	PF13516
Domain	-	FLNA EPHA6 CD244 SEMA7A ROR1 OBSCN CEACAM1 CD4 UMODL1 NEGR1 USH2A PLXNB1 FCMR	5.04e-04	663	125	13	2.60.40.10
Domain	SUSHI	CR1L SUSD5 C6 CSMD1	5.37e-04	56	125	4	PS50923
Domain	Sushi_SCR_CCP_dom	CR1L SUSD5 C6 CSMD1	5.74e-04	57	125	4	IPR000436
Domain	P-type_ATPase_IIC	ATP12A ATP4A	6.55e-04	6	125	2	IPR005775
Domain	Ig-like_fold	FLNA EPHA6 CD244 SEMA7A ROR1 OBSCN CEACAM1 CD4 UMODL1 NEGR1 USH2A PLXNB1 FCMR	9.03e-04	706	125	13	IPR013783
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	6.85e-09	12	89	5	M27326
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.71e-08	14	89	5	MM15052
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	4.99e-08	55	89	7	M971
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	6.44e-08	57	89	7	MM15643
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	6.48e-07	27	89	5	MM15053
Pathway	REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	7.85e-07	28	89	5	M924
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	SGK3 CLCNKA ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.62e-06	176	89	9	MM15718
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	SGK3 CLCNKA ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	2.24e-06	183	89	9	M997
Pathway	REACTOME_CARDIAC_CONDUCTION	CES1 KCND1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.82e-06	103	89	7	MM15196
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PTGIR ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	8.19e-06	76	89	6	MM15051
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA	ATP2A1 ATP2A2 ATP2A3	1.33e-05	8	89	3	M47955
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PTGIR ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.67e-05	86	89	6	M916
Pathway	REACTOME_CARDIAC_CONDUCTION	CES1 KCND1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.77e-05	130	89	7	M27454
Pathway	REACTOME_ION_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.22e-05	54	89	5	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.22e-05	54	89	5	MM15202
Pathway	REACTOME_HEMOSTASIS	FLNA CD244 CD177 PTGIR CEACAM1 PRCP VEGFD ATP2A1 ATP2A2 ATP2A3 KLKB1 ATP2B2 ATP2B3	5.73e-05	571	89	13	MM14472
Pathway	REACTOME_MUSCLE_CONTRACTION	CES1 KCND1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	8.16e-05	165	89	7	MM15026
Pathway	REACTOME_HEMOSTASIS	FLNA CD244 CD177 PTGIR CEACAM1 IGLV1-51 PRCP VEGFD ATP2A1 ATP2A2 ATP2A3 KLKB1 ATP2B2 ATP2B3	8.45e-05	679	89	14	M8395
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	ATP2A1 ATP2A2 ATP2A3	1.85e-04	18	89	3	M614
Pathway	REACTOME_MUSCLE_CONTRACTION	CES1 KCND1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.94e-04	203	89	7	M5485
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	SLC26A2 CUBN ABCB4 SGK3 MICU1 CLCNKA ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	6.88e-04	736	89	13	M27287
Pathway	BIOCARTA_ALTERNATIVE_PATHWAY	C3 C6	1.08e-03	8	89	2	MM1582
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	SLC26A2 ABCB4 SGK3 MICU1 CLCNKA ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.15e-03	681	89	12	MM14985
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	FLNA DST AMOT AFDN	1.16e-03	73	89	4	MM15126
Pathway	BIOCARTA_ALTERNATIVE_PATHWAY	C3 C6	1.38e-03	9	89	2	M22072
Pubmed	Biology, structure and mechanism of P-type ATPases.	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	1.13e-11	29	128	7	15071553
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.46e-11	8	128	5	10951186
Pubmed	The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors.	ATP2A1 ATP2A2 ATP2A3	4.87e-08	3	128	3	16410239
Pubmed	Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.	ATP2A1 ATP2A2 ATP2A3	1.94e-07	4	128	3	25110346
Pubmed	The nongastric H+-K+-ATPases: molecular and functional properties.	ATP2A1 ATP2A2 ATP2A3	1.94e-07	4	128	3	10362770
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.84e-07	38	128	5	30786075
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLNA INTS12 CES1 LYST TASOR2 ABCB4 DST ANTXR2 UMODL1 BOD1L1 ATP12A ATP2A1 ATP2A2 ATP2A3 FUBP3 ATP2B2 TOP3B ATP2B3 ZNF292 FCMR	3.31e-07	1442	128	20	35575683
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	CD244 PTGIR TNFRSF11B CD4 CD6 CCN1 UMODL1 TK2 HASPIN C3 C6 VEGFD IL7 PDZD2 FCMR	4.05e-07	824	128	15	20237496
Pubmed	Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange.	ATP2A2 ATP2B2 ATP2B3	9.66e-07	6	128	3	12767889
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	ATP2A1 ATP2A2 ATP2A3	1.69e-06	7	128	3	24786561
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	ATP2A1 ATP2A2 ATP2A3	2.69e-06	8	128	3	19033399
Pubmed	Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides.	ATP2A1 ATP2A2 ATP2A3	2.69e-06	8	128	3	27923914
Pubmed	Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.	CR1L C3 C6	4.02e-06	9	128	3	18947875
Pubmed	A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.	ATP2A1 ATP2A2 ATP2A3	4.02e-06	9	128	3	25640239
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	NUP88 ITPRID2 YEATS2 DST ZNF292 PDZD2	6.60e-06	123	128	6	26912792
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	ANTXR2 AFDN ATP2A1 ATP2A2 ATP2B2 ATP2B3 ATP4A	1.05e-05	202	128	7	24639526
Pubmed	Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice.	ATP2A1 ATP2A2	1.34e-05	2	128	2	12556521
Pubmed	Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases.	ATP12A ATP4A	1.34e-05	2	128	2	21164026
Pubmed	Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization.	C3 C6	1.34e-05	2	128	2	15611275
Pubmed	Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest.	ATP2A1 ATP2A2	1.34e-05	2	128	2	19644701
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles.	ATP2A1 ATP2A2	1.34e-05	2	128	2	14638697
Pubmed	Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26-->p25 and Xq28, respectively.	ATP2B2 ATP2B3	1.34e-05	2	128	2	8187550
Pubmed	Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).	PRCP KLKB1	1.34e-05	2	128	2	25324000
Pubmed	Impaired acid secretion in cortical collecting duct intercalated cells from H-K-ATPase-deficient mice: role of HKalpha isoforms.	ATP12A ATP4A	1.34e-05	2	128	2	18057185
Pubmed	Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.	ATP2A2 ATP2A3	1.34e-05	2	128	2	19650915
Pubmed	Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.	ATP2A2 ATP2A3	1.34e-05	2	128	2	19962989
Pubmed	Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm.	ATP2A1 ATP2A2	1.34e-05	2	128	2	15718407
Pubmed	Application of a high-throughput genotyping method for loci exclusion in non-consanguineous Australian pedigrees with autosomal recessive retinitis pigmentosa.	CRB1 USH2A	1.34e-05	2	128	2	22876132
Pubmed	SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis.	ATP2A1 ATP2A2	1.34e-05	2	128	2	11402072
Pubmed	Regulation of SERCA pumps expression in diabetes.	ATP2A2 ATP2A3	1.34e-05	2	128	2	25270119
Pubmed	Benzamil-mediated urine alkalization is caused by the inhibition of H+-K+-ATPases.	ATP12A ATP4A	1.34e-05	2	128	2	33554781
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology.	ATP2A1 ATP2A2	1.34e-05	2	128	2	10603953
Pubmed	Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight.	ATP2A1 ATP2A2	1.34e-05	2	128	2	34769190
Pubmed	Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.	ATP2A2 ATP2A3	1.34e-05	2	128	2	18295663
Pubmed	Training induced decrease in oxygen cost of cycling is accompanied by down-regulation of SERCA expression in human vastus lateralis muscle.	ATP2A1 ATP2A2	1.34e-05	2	128	2	18953100
Pubmed	SERCA overexpression reduces hydroxyl radical injury in murine myocardium.	ATP2A1 ATP2A2	1.34e-05	2	128	2	16798816
Pubmed	Mechanisms of control of the free Ca2+ concentration in the endoplasmic reticulum of mouse pancreatic β-cells: interplay with cell metabolism and [Ca2+]c and role of SERCA2b and SERCA3.	ATP2A2 ATP2A3	1.34e-05	2	128	2	21885870
Pubmed	Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.	ATP2A1 ATP2A2	1.34e-05	2	128	2	12975374
Pubmed	Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility.	C3 CSMD1	1.34e-05	2	128	2	31604923
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ROR1 OBSCN FOCAD DIP2A DST AMOT MYO3B BOD1L1 C6 CFAP418 ARHGAP20 FUBP3	1.87e-05	736	128	12	29676528
Pubmed	SERCA and PMCA pumps contribute to the deregulation of Ca2+ homeostasis in human CF epithelial cells.	ATP2A2 ATP2B2	4.02e-05	3	128	2	25661196
Pubmed	Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.	ATP2A1 ATP2A2	4.02e-05	3	128	2	27055500
Pubmed	Cutting Edge: 2B4-Mediated Coinhibition of CD4+ T Cells Underlies Mortality in Experimental Sepsis.	CD244 CD4	4.02e-05	3	128	2	28768726
Pubmed	Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.	ATP2A1 ATP2A2	4.02e-05	3	128	2	25615793
Pubmed	Modulation of endoplasmic reticulum calcium pump by Bcl-2.	ATP2A2 ATP2A3	4.02e-05	3	128	2	9788433
Pubmed	Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.	ATP2A2 ATP2A3	4.02e-05	3	128	2	16973504
Pubmed	The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless.	AMN1 CUBN	4.02e-05	3	128	2	14576052
Pubmed	Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.	ATP2A1 ATP2A2	4.02e-05	3	128	2	15972723
Pubmed	Primary cilia are not required for normal canonical Wnt signaling in the mouse embryo.	DYNC2H1 IFT172	4.02e-05	3	128	2	19718259
Pubmed	A critical role for murine complement regulator crry in fetomaternal tolerance.	CR1L C3	4.02e-05	3	128	2	10642554
Pubmed	Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.	ATP2A1 ATP2A2	4.02e-05	3	128	2	16754798
Pubmed	Increased sensitivity to K+ deprivation in colonic H,K-ATPase-deficient mice.	ATP12A ATP4A	4.02e-05	3	128	2	9449685
Pubmed	SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.	SGK3 ATP2A2	4.02e-05	3	128	2	28174265
Pubmed	Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain.	C3 C6	4.02e-05	3	128	2	26822321
Pubmed	CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.	CD4 IL7	4.02e-05	3	128	2	21257970
Pubmed	Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.	ATP2A2 ATP2A3	4.02e-05	3	128	2	19419309
Pubmed	SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity.	SELENON ATP2A2	4.02e-05	3	128	2	25452428
Pubmed	Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.	ATP2A1 ATP2A2	4.02e-05	3	128	2	11526231
Pubmed	Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3.	ATP2A2 ATP2A3	4.02e-05	3	128	2	15161756
Pubmed	Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.	VEGFD IL7	4.02e-05	3	128	2	24115038
Pubmed	Inhibition of NKp30- and 2B4-mediated NK cell activation by evolutionary different human and bovine CEACAM1 receptors.	CD244 CEACAM1	4.02e-05	3	128	2	25824372
Pubmed	Genome-Wide Detection of Copy Number Variations in Unsolved Inherited Retinal Disease.	RIMS3 USH2A	4.02e-05	3	128	2	28118666
Pubmed	Complement production by trophoblast cells at the feto-maternal interface.	C3 C6	4.02e-05	3	128	2	19665237
Pubmed	CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration.	FLNA CEACAM1	4.02e-05	3	128	2	16291724
Pubmed	Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapy.	CD4 IL7	4.02e-05	3	128	2	21209878
Pubmed	Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.	ATP2A1 ATP2A2	4.02e-05	3	128	2	9038922
Pubmed	Specific effects of endurance and sprint training on protein expression of calsequestrin and SERCA in mouse skeletal muscle.	ATP2A1 ATP2A2	4.02e-05	3	128	2	22466636
Pubmed	The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of angiomotin.	CRB1 AMOT AFDN	7.12e-05	22	128	3	27521426
Pubmed	The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA Activity to Control ER-Isolation Membrane Contacts for Autophagosome Formation.	ATP2A1 ATP2A2 ATP2A3	7.12e-05	22	128	3	28890335
Pubmed	Differences between germ-line and rearranged immunoglobulin V kappa coding sequences suggest a localized mutation mechanism.	IGKV6D-21 IGKV6-21	8.02e-05	4	128	2	6264318
Pubmed	Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons.	ATP2B2 ATP2B3	8.02e-05	4	128	2	12209837
Pubmed	Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis.	CR1L C3	8.02e-05	4	128	2	24632830
Pubmed	Expression and role of calcium-ATPase pump and sodium-calcium exchanger in differentiated trophoblasts from human term placenta.	ATP2B2 ATP2B3	8.02e-05	4	128	2	12784250
Pubmed	Utility of molecular testing for related retinal dystrophies.	CRB1 USH2A	8.02e-05	4	128	2	16767206
Pubmed	The plasma membrane calcium pump in health and disease.	ATP2B2 ATP2B3	8.02e-05	4	128	2	23413890
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B2 ATP2B3	8.02e-05	4	128	2	8245032
Pubmed	DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.	CR1L C3	8.02e-05	4	128	2	16887189
Pubmed	Membrane protein Crry maintains homeostasis of the complement system.	CR1L C3	8.02e-05	4	128	2	18684964
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	DYNC2H1 OBSCN	8.02e-05	4	128	2	26147384
Pubmed	Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.	CR1L C3	8.02e-05	4	128	2	16127466
Pubmed	What are those cilia doing in the neural tube?	DYNC2H1 IFT172	8.02e-05	4	128	2	23351466
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B2 ATP2B3	8.02e-05	4	128	2	7989379
Pubmed	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	ATP2B2 ATP2B3	8.02e-05	4	128	2	11152753
Pubmed	Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart.	ATP2A1 ATP2A2	8.02e-05	4	128	2	9295312
Pubmed	STUDIES ON THE INTERACTION OF VITAMIN B12: INTRINSIC FACTOR AND RECEPTORS. 3. CHEMICAL AND BIOLOGICAL PROPERTIES OF VITAMIN B12 COMBINING SUBSTANCES FROM THE STOMACH, SERUM, AND ASCITES FLUID OF THE MOUSE.	AMN1 CUBN	8.02e-05	4	128	2	14321840
Pubmed	PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†.	ATP2B2 ATP2B3	8.02e-05	4	128	2	36130203
Pubmed	Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.	CR1L C3	8.02e-05	4	128	2	12393518
Pubmed	Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse.	ATP2B2 ATP2B3	8.02e-05	4	128	2	10434059
Pubmed	Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.	ATP2A1 ATP2A2	8.02e-05	4	128	2	10555147
Pubmed	SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets.	ATP2A2 ATP2A3	8.02e-05	4	128	2	18068335
Pubmed	Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7.	CD4 IL7	8.02e-05	4	128	2	16763207
Pubmed	Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.	LYST CD4	8.02e-05	4	128	2	27488533
Pubmed	Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs).	ATP2A1 ATP2A2	8.02e-05	4	128	2	12032137
Pubmed	Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.	LYST CD4	8.02e-05	4	128	2	11152110
Pubmed	Calcium pumps of plasma membrane and cell interior.	ATP2B2 ATP2B3	8.02e-05	4	128	2	15101689
Pubmed	Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function.	ATP2B2 ATP2B3	8.02e-05	4	128	2	10577388
Pubmed	Structural organization, ion transport, and energy transduction of P-type ATPases.	ATP2B2 ATP2B3	8.02e-05	4	128	2	8634322
Pubmed	Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle.	ATP2A1 ATP2A2	8.02e-05	4	128	2	12074580
Pubmed	Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.	CR1L C3	8.02e-05	4	128	2	30217731
Pubmed	SERCA1a can functionally substitute for SERCA2a in the heart.	ATP2A1 ATP2A2	8.02e-05	4	128	2	9887021
GeneFamily	ATPases Ca2+ transporting	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	5.23e-10	9	98	5	1209
GeneFamily	ATPase H+/K+ transporting	ATP12A ATP4A	8.69e-05	3	98	2	1211
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	IFT172 BBS7 CFAP418	1.91e-04	21	98	3	980
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CR1L SUSD5 C6 CSMD1	2.57e-04	57	98	4	1179
GeneFamily	Complement system\|Sushi domain containing	CR1L C3 C6	9.68e-04	36	98	3	492
Coexpression	TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2 ARHGAP20	1.25e-06	164	125	8	M41676
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN MYO3B CLPS C6 ATP12A USH2A KLKB1 ATP2B2	3.27e-08	169	128	8	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Control-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	CPNE2 CD177 CNST CD4 ANTXR2 PHLPP1 IL7 ZNF292	6.59e-08	185	128	8	e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A6 PTGIR DST CCN1 NEGR1 MRC2 VEGFD	1.11e-07	198	128	8	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2 ARHGAP20	1.16e-07	199	128	8	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR CCN1 MRC2 C3 ARHGAP20 VEGFD	1.16e-07	199	128	8	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2 ARHGAP20	1.16e-07	199	128	8	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR CCN1 MRC2 C3 ARHGAP20 VEGFD	1.16e-07	199	128	8	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2 ARHGAP20	1.16e-07	199	128	8	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A6 PTGIR DST CCN1 NEGR1 MRC2 VEGFD	1.16e-07	199	128	8	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	cellseq-Mesenchymal-Fibroblastic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A6 PTGIR DST CCN1 NEGR1 MRC2 VEGFD	1.20e-07	200	128	8	8978867bf69c830b1e48cac2ad6b512dbe60f149
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 CES1 PTGIR TNFRSF11B DST CCN1 NEGR1 ARHGAP20	1.20e-07	200	128	8	750ff51c9de08aecec230f4a402e0bf5a789f24c
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	USP53 EPHA6 DYNC2H1 PTGIR NEGR1 C3 VEGFD	1.32e-06	190	128	7	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	COPD-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	CPNE2 CD177 CNST CD4 ANTXR2 PHLPP1 ZNF292	1.36e-06	191	128	7	3ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A6 PTGIR DST CCN1 NEGR1 MRC2 VEGFD	1.57e-06	195	128	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A6 PTGIR DST CCN1 NEGR1 MRC2 VEGFD	1.57e-06	195	128	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GRID1 PRSS23 PTGIR ANTXR2 NEGR1 MRC2	1.57e-06	195	128	7	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.62e-06	196	128	7	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A6 PTGIR DST CCN1 NEGR1 MRC2 VEGFD	1.62e-06	196	128	7	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.62e-06	196	128	7	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.68e-06	197	128	7	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA PRSS23 PTGIR ANTXR2 CCN1 NEGR1 MRC2	1.68e-06	197	128	7	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD177 CNST PTGIR CEACAM1 CD4 IL7 FCMR	1.68e-06	197	128	7	54fb7197db3c0dc87a1114e1ab1d2bfafd564b35
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.68e-06	197	128	7	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD177 CNST PTGIR CEACAM1 CD4 IL7 FCMR	1.73e-06	198	128	7	03423d6c614440b9c738f75ac3f5a6941719a279
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A6 DYNC2H1 PRSS23 DST MRC2 ARHGAP20 VEGFD	1.79e-06	199	128	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A6 SQLE PTGIR TNFRSF11B CCN1 MRC2 C3	1.79e-06	199	128	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A6 DYNC2H1 PRSS23 DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2	1.85e-06	200	128	7	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2	1.85e-06	200	128	7	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	Parenchymal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 CES1 PTGIR DST CCN1 NEGR1 C3	1.85e-06	200	128	7	f6be0f24e607abb9007823a54fb0b24d04990a89
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	USP53 COL6A6 CES1 PTGIR DST CCN1 MRC2	1.85e-06	200	128	7	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A6 DYNC2H1 PTGIR DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A6 PRSS23 PTGIR DST MRC2 ARHGAP20 VEGFD	1.85e-06	200	128	7	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	distal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A6 CES1 PTGIR DST CCN1 MRC2 ARHGAP20	1.85e-06	200	128	7	20112be28f80baffad92641c9cfd7c3718967dbb
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHA6 CRB1 SUSD5 ATP12A USH2A ATP2B3	3.96e-06	145	128	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FLNA CES1 ROR1 PRSS23 CD4 CD6	5.40e-06	153	128	6	764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLIN4 NEGR1 C3 C6 ARHGAP20 VEGFD	7.23e-06	161	128	6	a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHA6 SUSD5 ATP12A USH2A KLKB1 ATP2B3	7.50e-06	162	128	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NHLRC1 CD177 PTGIR CD4 PHLPP1 FBXL2	7.76e-06	163	128	6	bca9abd02ffb2a90c8386a59f5e25126ae7b6acd
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3\|TCGA-Uterus / Sample_Type by Project: Shred V9	SLC26A2 LYST CEACAM1 DST ENTPD3 PDZD2	7.76e-06	163	128	6	d64dd39b077105c73e570ccef70f0e74a2c586ac
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA CD177 LYST CEACAM1 ANTXR2 C3	1.02e-05	171	128	6	ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA CD177 LYST CEACAM1 ANTXR2 C3	1.02e-05	171	128	6	97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	USP53 CD177 SLC26A2 ITPRID2 CEACAM1 DST	1.02e-05	171	128	6	0de81d12a8000f2c59cdb214e67dc526d18098fe
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	USP53 CD177 SLC26A2 ITPRID2 CEACAM1 DST	1.02e-05	171	128	6	0597339618fb4d416d55c538eceb353218a55002
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD4 DST NEGR1 GPR137B C6 ATP12A	1.05e-05	172	128	6	7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN MYO3B CLPS C3 ATP12A USH2A	1.09e-05	173	128	6	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN MYO3B CLPS C3 ATP12A USH2A	1.09e-05	173	128	6	649b08a409095592cccf31883be69c754411280d
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLIN4 TASOR2 TRIM66 AMOT FUBP3 PLXNB1	1.20e-05	176	128	6	87de432c680b80555342afac864599bbc002c040
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA CD177 LYST PTGIR CEACAM1 C3	1.24e-05	177	128	6	065bebd22031f143e90a407f952b444a3f8818c7
ToppCell	facs-Marrow-Granulocytes-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA CD177 LYST PTGIR CEACAM1 C3	1.24e-05	177	128	6	eb304f20aab075bd17aa3aef819386c0e1a235bd
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	USP53 ABCB4 CD4 BBS7 C3 IL7	1.32e-05	179	128	6	06d412fc096d88de168969466ce422f0ab5553b2
ToppCell	390C-Fibroblasts-Fibroblast-G\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.37e-05	180	128	6	137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell	390C-Fibroblasts-Fibroblast-G-\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.37e-05	180	128	6	cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 FLNA CES1 PRSS23 CCN1 NEGR1	1.45e-05	182	128	6	7b86703559438e2d5ef3dad963ee0d772513f313
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A6 PTGIR DST CCN1 MRC2 VEGFD	1.64e-05	186	128	6	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	IPF-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	CPNE2 CD177 CNST CD4 PHLPP1 ZNF292	1.80e-05	189	128	6	7a260485c2a7c743c14d048e5e480ae0a9b8e32c
ToppCell	COVID-19_Mild-Treg\|COVID-19_Mild / Disease condition and Cell class	CPNE2 PTGIR CD4 ANTXR2 IL7 FCMR	1.80e-05	189	128	6	f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR1 GRID1 PTGIR NEGR1 MRC2 SUSD5	1.85e-05	190	128	6	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR ANTXR2 NEGR1 MRC2 ARHGAP20	1.91e-05	191	128	6	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	COVID-19_Severe-Treg\|COVID-19_Severe / Disease condition and Cell class	CPNE2 PTGIR CD4 ANTXR2 IL7 FCMR	1.91e-05	191	128	6	06fdd76ea13b93e29959c745698b57af6746aaeb
ToppCell	Severe-Treg\|World / Disease group and Cell class	PTGIR CEACAM1 CD4 CLCNKA IL7 FCMR	1.91e-05	191	128	6	0a80b8c317e8da4d4722cfd13cdabc32b58021eb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR1 PRSS23 PTGIR ANTXR2 NEGR1 MRC2	1.91e-05	191	128	6	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	EPHA6 DYNC2H1 NEGR1 MRC2 C3 VEGFD	1.91e-05	191	128	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR ANTXR2 NEGR1 MRC2 ARHGAP20	1.91e-05	191	128	6	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR1 PRSS23 PTGIR ANTXR2 NEGR1 MRC2	1.91e-05	191	128	6	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 PRSS23 SELENON ANTXR2 MRC2 C3	1.97e-05	192	128	6	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	INTS12 COL6A6 DST ANTXR2 CCN1 VEGFD	1.97e-05	192	128	6	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	FLNA CD244 CES1 PRSS23 DIP2A CD6	2.09e-05	194	128	6	73c057b623829de793616d9d373a0018071d51d8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR DST ANTXR2 CCN1 NEGR1	2.09e-05	194	128	6	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR DST ANTXR2 CCN1 NEGR1	2.09e-05	194	128	6	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	PRSS23 LYST TNFRSF11B SHROOM4 PRCP C6	2.09e-05	194	128	6	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 FLNA CES1 PRSS23 CCN1 NEGR1	2.09e-05	194	128	6	d2bafd31bb8333f66b6c714944bceb2f1aa11740
ToppCell	3'_v3-Lung-Myeloid_Dendritic\|Lung / Manually curated celltypes from each tissue	SEMA7A ROR1 PTGIR TNFRSF11B NEGR1 MRC2	2.15e-05	195	128	6	b748cb15846345363e8c2ee5936bb42bba3ba9a7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GRID1 ANTXR2 CCN1 NEGR1 MRC2	2.15e-05	195	128	6	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA PRSS23 PTGIR ANTXR2 NEGR1 MRC2	2.15e-05	195	128	6	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	DYNC2H1 PTGIR ANTXR2 NEGR1 MRC2 C3	2.15e-05	195	128	6	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	Control-Treg\|Control / Disease condition and Cell class	CPNE2 PTGIR CD4 ANTXR2 IL7 FCMR	2.15e-05	195	128	6	bbe9789eb2c17f43de55b2e6d01d1093c64dc666
ToppCell	Healthy_Control-Myeloid-mDC\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	USP53 PTGIR TNFRSF11B ABCB4 ANTXR2 AMOT	2.15e-05	195	128	6	32f505b2c24f4386367706b775e79271f99156f2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GRID1 ANTXR2 CCN1 NEGR1 MRC2	2.15e-05	195	128	6	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	USP53 COL6A6 PTGIR DST CCN1 NEGR1	2.15e-05	195	128	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR ANTXR2 NEGR1 MRC2 C3	2.15e-05	195	128	6	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	Healthy_Control-Myeloid-mDC-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	USP53 PTGIR TNFRSF11B ABCB4 ANTXR2 AMOT	2.15e-05	195	128	6	d9a6fc7fa0047472821e1dcf0962ccb3f061313e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 DYNC2H1 DST BOD1L1 ATP2A2 ATP2A3	2.15e-05	195	128	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA PRSS23 PTGIR ANTXR2 NEGR1 MRC2	2.15e-05	195	128	6	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 DYNC2H1 DST BOD1L1 ATP2A2 ATP2A3	2.15e-05	195	128	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	USP53 COL6A6 CES1 DST AFDN VEGFD	2.21e-05	196	128	6	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	USP53 COL6A6 CES1 DST AFDN VEGFD	2.21e-05	196	128	6	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR ANTXR2 CCN1 NEGR1 MRC2	2.21e-05	196	128	6	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GRID1 PRSS23 PTGIR NEGR1 MRC2	2.21e-05	196	128	6	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA GRID1 PRSS23 PTGIR NEGR1 MRC2	2.21e-05	196	128	6	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	COL6A6 CES1 DYNC2H1 MRC2 ARHGAP20 VEGFD	2.27e-05	197	128	6	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR ANTXR2 CCN1 NEGR1 MRC2	2.27e-05	197	128	6	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRSS23 PTGIR ANTXR2 CCN1 NEGR1 MRC2	2.27e-05	197	128	6	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLIN4 FLNA PRSS23 CCN1 SUSD5 PDZD2	2.27e-05	197	128	6	1a6b2ca94a4634c24cd95481576c955b20000a5f
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	COL6A6 PTGIR DST CCN1 MRC2 VEGFD	2.27e-05	197	128	6	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	3'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	USP53 SLC26A2 SQLE ITPRID2 TNFRSF11B CEACAM1	2.34e-05	198	128	6	7ad7726fc405806b1d7824f58548073ea5e0c70b
Computational	Genes upregulated in subsets of cells of a given type within various tumors	USP53 CES1 DST CCN1 VEGFD	2.31e-05	49	76	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3
Drug	1sqc	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.13e-09	10	125	5	CID000444279
Drug	gramicidin s	IARS2 CD6 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.14e-09	37	125	7	CID000073357
Drug	2,5-dimethylquinone	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.07e-09	11	125	5	CID000008718
Drug	AC1L25Y6	ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.27e-09	23	125	6	CID000015465
Drug	1vyq	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.53e-09	12	125	5	CID004369390
Drug	p-hydroxyhippuric acid	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	8.86e-09	14	125	5	CID000151012
Drug	AC1L88YH	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.70e-08	17	125	5	CID000374551
Drug	lanthanum chloride hydrate	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.43e-07	23	125	5	CID000165791
Drug	agelasine B	TK2 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.90e-07	46	125	6	CID006439899
Drug	cyhexatin	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.24e-07	25	125	5	CID005364545
Drug	dodecyl ether	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.76e-07	26	125	5	CID000020667
Drug	octaethylene glycol	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	4.92e-07	29	125	5	CID000078798
Drug	AC1L1JAO	PTGIR ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	7.00e-07	57	125	6	CID000004955
Drug	AC1NSKPI	ABCB4 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	7.00e-07	57	125	6	CID005311482
Drug	fluorescamine	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.31e-06	35	125	5	CID000037927
Drug	mag-fura-2	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.74e-06	37	125	5	CID000123839
Drug	chlordecone	C3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.84e-06	67	125	6	CID000000299
Drug	caged ATP	ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.39e-06	70	125	6	CID000123806
Drug	Pyrethroids	CES1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.60e-06	71	125	6	CID000005053
Drug	carbidine	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.60e-06	40	125	5	CID000065684
Drug	cocaethylene	CES1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.06e-06	73	125	6	CID000002825
Drug	C12E8	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.33e-06	42	125	5	CID000123921
Drug	divicine	C3 ATP2A1 ATP2A3 ATP2B2	7.07e-06	23	125	4	CID000091606
Drug	AC1L1G0K	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	7.23e-06	49	125	5	CID000003473
Drug	AC1L1IZE	NLRP14 DCLRE1A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	8.07e-06	131	125	7	CID000004799
Drug	lanthanum	KCND1 ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.03e-05	136	125	7	CID000023926
Drug	1,4-dibromobutane	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.07e-05	53	125	5	CID000008056
Drug	R 8231	ATP2A1 ATP2A3 ATP2B2	1.32e-05	9	125	3	CID003084926
Drug	toxaphene	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.67e-05	58	125	5	CID005284469
Drug	ethylketocyclazocine	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.67e-05	58	125	5	CID000135018
Drug	fluorescein isothiocyanate	LYST CD4 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.71e-05	147	125	7	CID000018730
Drug	AC1NS1NG	NHLRC1 CD4 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.71e-05	147	125	7	CID005327099
Drug	tricyclohexyltin chloride	ATP2A1 ATP2A3 ATP2B2	1.88e-05	10	125	3	CID000076539
Drug	ATP-EDC	ATP2A1 ATP2A2 ATP2A3	1.88e-05	10	125	3	CID000195647
Drug	dithionite	RNMT C3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.95e-05	150	125	7	CID000001086
Drug	sanguinarine	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.97e-05	60	125	5	CID000005154
Drug	DCCD	PTGIR ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.04e-05	151	125	7	CID000010868
Drug	vitamin D3	LYST TNFRSF11B CD4 ZFYVE9 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.29e-05	277	125	9	CID000002735
Drug	persulfate	ATP2A1 ATP2A3 ATP2B2	2.58e-05	11	125	3	CID000024413
Drug	strontium	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.64e-05	68	125	5	CID000104798
Drug	tBuBHQ	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.91e-05	69	125	5	CID000002374
Drug	L-beta-aspartyl phosphate	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	3.91e-05	69	125	5	CID000000832
Drug	NSC381866	ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3 ATP4A	4.19e-05	169	125	7	CID000002287
Drug	3,4-dichloroaniline	PRSS23 CEACAM1 DST ANTXR2 CCN1 ENTPD3 C3	4.52e-05	171	125	7	ctd:C014464
Drug	2-butenedioate	CES1 AMOT C3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	4.63e-05	234	125	8	CID000000723
Drug	AC1L1IIA	NLRP14 ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	4.69e-05	172	125	7	CID000004591
Drug	monobromobimane	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	4.80e-05	72	125	5	CID000114810
Drug	Les T	FLNA LYST MRC2 ATP2A1 ATP2A2 ATP2A3	6.11e-05	123	125	6	CID000003189
Drug	trimethyl phosphate	DST ATP2A1 ATP2A2 ATP2A3	6.14e-05	39	125	4	CID000010541
Drug	carbonyl cyanide m-chlorophenylhydrazone	IARS2 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	6.68e-05	125	125	6	CID000002603
Drug	phosphocreatine disodium	ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	6.98e-05	126	125	6	CID000000587
Drug	NSC239129	ATP2A1 ATP2A2 ATP2A3	7.00e-05	15	125	3	CID000084597
Drug	VSVs	TNFRSF11B CD4	8.94e-05	3	125	2	CID009549796
Drug	dihydrolinalool	CD4 CD6	8.94e-05	3	125	2	CID000086749
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	TNFRSF11B GHRHR ZFYVE9 TK2 FBXL2 PDZD2 FCMR	1.00e-04	194	125	7	4424_DN
Drug	XeC compound	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.00e-04	84	125	5	CID000005701
Drug	succinate	SLC26A2 NEGR1 C3 ARHGAP20 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.09e-04	339	125	9	CID000001110
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	ROR1 RIMS3 TRIM66 CD4 CIBAR1 PLXNB1 FCMR	1.10e-04	197	125	7	2061_UP
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	KDM4C ZNF407 TNFRSF11B CD6 MRC2 AFDN IL7	1.10e-04	197	125	7	7283_UP
Drug	UTP-NA	FLNA GTF3C4 NLRP14 TK2 ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.10e-04	420	125	10	CID000001181
Drug	magnesium	DIRAS1 SQLE ABCB4 IARS2 NLRP14 ANTXR2 CLCNKA TK2 ENTPD3 HASPIN C3 ATP12A ATP2A1 ATP2A2 ATP2A3 ATP2B2 TOP3B ATP2B3 ATP4A	1.11e-04	1325	125	19	CID000000888
Drug	Caffeic acid [3331-39-5]; Down 200; 22.2uM; HL60; HT_HG-U133A	USP53 DYNC2H1 CD6 AFDN ATP2A2 TOP3B FCMR	1.14e-04	198	125	7	3053_DN
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	GHRHR ENTPD3 C3 C6 ATP2B2 PDZD2 FCMR	1.17e-04	199	125	7	3934_UP
Drug	xenon	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.25e-04	88	125	5	CID000023991
Drug	LaCl3	SQLE ATP2A1 ATP2A3 ATP2B2	1.29e-04	47	125	4	CID000064735
Drug	clotrimazole	KCND1 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.40e-04	143	125	6	CID000002812
Drug	AC1L380G	ATP2A1 ATP2A2 ATP2A3	1.47e-04	19	125	3	CID000084698
Drug	MgCl2	IARS2 MYO3B ENTPD3 AFDN ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.51e-04	354	125	9	CID000024584
Drug	AC1MMLID	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.55e-04	92	125	5	CID000013245
Drug	carbonyl cyanide	SLC26A2 ATP2A1 ATP2A3 ATP2B2	1.64e-04	50	125	4	CID000517957
Drug	gamma-terpineol	CD4 CD6	1.78e-04	4	125	2	CID000011467
Drug	abrine	USP53 FLNA CD244 PRSS23 CLCNKA MYO3B C3 KLKB1	1.82e-04	285	125	8	ctd:C496492
Drug	milrinone	PTGIR ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.82e-04	150	125	6	CID000004197
Drug	nitrous oxide	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	1.89e-04	96	125	5	CID000000948
Drug	Phosphoryl	TK2 ATP2A1 ATP2A2 ATP2A3 ATP2B2 TOP3B ATP2B3	1.89e-04	215	125	7	CID006857426
Drug	compound 48/80	ATP2A1 ATP2A2 ATP2A3 KLKB1 ATP2B2 ATP2B3	1.89e-04	151	125	6	CID000104735
Drug	lead citrate	ATP2A1 ATP2A3 ATP2B2	2.00e-04	21	125	3	CID000159739
Drug	2brh	ATP2A2 ATP2B2 ATP2B3	2.00e-04	21	125	3	CID000848641
Drug	acetyl phosphate	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.08e-04	98	125	5	CID000000186
Drug	indo-1	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.18e-04	99	125	5	CID000105060
Drug	CaCl2	ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.25e-04	156	125	6	CID000024854
Drug	S-(-)-Etomoxir	CES1 SQLE MYO3B AFDN ATP2A2	2.28e-04	100	125	5	CID000060765
Drug	FCCP	ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.39e-04	101	125	5	CID000003330
Drug	oxalate	SLC26A2 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.41e-04	158	125	6	CID000000971
Drug	NL-4	CD4 ATP2A1 ATP2A3 IL7	2.55e-04	56	125	4	CID016074496
Drug	calmidazolium chloride	SQLE ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.58e-04	160	125	6	CID000002531
Drug	2-(aminomethyl)pyrrolidine	ENTPD3 ATP2A1 ATP2A2 ATP2A3 ATP2B2 ATP2B3	2.67e-04	161	125	6	CID000072032
Disease	Brody myopathy (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	6.56e-08	3	120	3	DOID:0050692 (implicated_via_orthology)
Disease	Ciliopathies	DYNC2H1 CRB1 BBS7 CIBAR1 USH2A	8.91e-05	110	120	5	C4277690
Disease	retinitis pigmentosa (implicated_via_orthology)	CRB1 CFAP418 USH2A	1.79e-04	27	120	3	DOID:10584 (implicated_via_orthology)
Disease	VACTERL association (implicated_via_orthology)	DYNC2H1 IFT172	2.43e-04	6	120	2	DOID:14679 (implicated_via_orthology)
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B2 ATP2B3	2.43e-04	6	120	2	DOID:0050429 (implicated_via_orthology)
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP12A ATP4A	3.40e-04	7	120	2	DOID:0060178 (implicated_via_orthology)
Disease	progressive familial intrahepatic cholestasis (is_implicated_in)	USP53 SEMA7A	3.40e-04	7	120	2	DOID:0070221 (is_implicated_in)
Disease	Osteolysis	TNFRSF11B ANTXR2	3.40e-04	7	120	2	C4721411
Disease	atrioventricular septal defect (implicated_via_orthology)	IFT172 CCN1	3.40e-04	7	120	2	DOID:0050651 (implicated_via_orthology)
Disease	programmed cell death 1 ligand 2 measurement	DHX36 KLKB1	4.52e-04	8	120	2	EFO_0008268
Disease	tyrosine-protein kinase JAK2 measurement	CPNE2 KLKB1	4.52e-04	8	120	2	EFO_0020825
Disease	heart disease (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	4.99e-04	38	120	3	DOID:114 (implicated_via_orthology)
Disease	isovalerate measurement	CD4 USH2A	5.80e-04	9	120	2	EFO_0021051
Disease	Retinitis Pigmentosa	IFT172 CRB1 CFAP418 USH2A	8.74e-04	104	120	4	C0035334
Disease	carbohydrate measurement	TNFRSF11B ANTXR2 ATP2B2	8.76e-04	46	120	3	EFO_0004998
Disease	Jeune thoracic dystrophy	DYNC2H1 IFT172	8.81e-04	11	120	2	C0265275
Disease	vascular endothelial growth factor D measurement	VEGFD KLKB1	8.81e-04	11	120	2	EFO_0010575
Disease	cell growth regulator with EF hand domain protein 1 measurement	CPNE2 GPR137B	8.81e-04	11	120	2	EFO_0801461
Disease	nervous system disease (implicated_via_orthology)	ATP12A ATP4A	1.05e-03	12	120	2	DOID:863 (implicated_via_orthology)
Disease	tyrosine-protein kinase ZAP-70 measurement	C3 C6	1.05e-03	12	120	2	EFO_0020833
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 IFT172	1.24e-03	13	120	2	C0036996
Disease	Bardet-Biedl Syndrome	IFT172 CFAP418	1.24e-03	13	120	2	C0752166
Disease	susceptibility to rubella infection measurement	NHLRC1 NEGR1 PDZD2	1.25e-03	52	120	3	EFO_0008418
Disease	triacylglycerol 46:2 measurement	MYO3B CSMD1	1.45e-03	14	120	2	EFO_0010402
Disease	Saldino-Noonan Syndrome	DYNC2H1 IFT172	1.45e-03	14	120	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 IFT172	1.45e-03	14	120	2	C0024507
Disease	phenylalanine measurement	NHLRC1 KLKB1 ATP2B2	1.48e-03	55	120	3	EFO_0005001
Disease	complement factor H-related protein 1 measurement	CPNE2 CRB1 MYO3B	1.55e-03	56	120	3	EFO_0600054
Disease	quinate measurement	KDM4C GRID1	1.66e-03	15	120	2	EFO_0021167
Disease	Intrahepatic cholestasis of pregnancy	ABCB4 ATP4A	1.90e-03	16	120	2	EFO_0009048
Disease	lupus nephritis (is_marker_for)	TNFRSF11B C3	2.14e-03	17	120	2	DOID:0080162 (is_marker_for)
Disease	glomerulonephritis (implicated_via_orthology)	C3 C6	2.14e-03	17	120	2	DOID:2921 (implicated_via_orthology)
Disease	COVID-19 (is_marker_for)	CD4 C3 IL7	2.18e-03	63	120	3	DOID:0080600 (is_marker_for)
Disease	glucose homeostasis measurement, acute insulin response measurement	ATP2A2 ATP2A3	2.40e-03	18	120	2	EFO_0006831, EFO_0006896
Disease	osteochondrodysplasia (is_implicated_in)	FLNA SLC26A2	2.68e-03	19	120	2	DOID:2256 (is_implicated_in)
Disease	Multiple Epiphyseal Dysplasia	FLNA SLC26A2	2.97e-03	20	120	2	C0026760
Disease	alpha-tocopherol measurement	KDM4C USH2A	2.97e-03	20	120	2	EFO_0007898
Disease	Retinitis pigmentosa	CRB1 CFAP418 USH2A	3.45e-03	74	120	3	cv:C0035334
Disease	Disproportionate short stature	FLNA DYNC2H1 SLC26A2	3.85e-03	77	120	3	C0878659
Disease	arginine measurement	CSMD1 KLKB1	3.92e-03	23	120	2	EFO_0020990

Protein segments in the cluster

Peptide	Gene	Start	Entry
QGCGADVSTTLTIKT	UMODL1	381	Q5DID0
KITSVSTGNLCTEEQ	AFDN	1196	P55196
EQIAITAGCKTTTSA	CES1	266	P23141
SESVTSIQGGCVGKD	BBS7	286	Q8IWZ6
KTGSRDCSTQTERGT	AMOT	856	Q4VCS5
LGQFSCSLGTIVSSK	CPNE2	111	Q96FN4
SVTSEGIKAVASSCS	AMN1	101	Q8IY45
GFVKTQGSESITCIL	CSMD1	726	Q96PZ7
LSSTCIVDVGDQKTS	ACTR8	276	Q9H981
KTCGTGISTRVTNDN	CCN1	241	O00622
KSVISGSLIVTATEC	ANTXR2	301	P58335
TSVRASIEGLGKSCS	CFAP418	91	Q96NL8
KDSCVGSLVVKSGQS	C3	556	P01024
TSTLVGTKGCSTVGA	CD177	256	Q8N6Q3
SVICSDKTGTLTTNQ	ATP2A1	346	O14983
SVICSDKTGTLTTNQ	ATP2A3	346	Q93084
GNATAICSDKTGTLT	ATP2B2	491	Q01814
NATAICSDKTGTLTT	ATP2B3	466	Q16720
VSQTFKCSVKGSGIS	ENTPD3	86	O75355
TGLSRSVSCDNVSKV	INTS12	371	Q96CB8
RLTNGSSSCSGTVEV	CD6	46	P30203
VSITNSSLKGISEGC	FBXL2	141	Q9UKC9
STIAGKIFGSICSLS	KCND1	381	Q9NSA2
SVENGKTNSVVTCSG	MAP10	261	Q9P2G4
SKGLCTSVTLAASEG	MAGEE1	121	Q9HCI5
NEGTNVTLTCLATGK	NEGR1	151	Q7Z3B1
LCSKESISGGGTEIS	DST	3036	Q03001
EKVTITCRASQSIGS	IGKV6-21	36	A0A0C4DH24
TLGSTSIICSDKTGT	ATP12A	381	P54707
SSGSGCVKVQSIEGD	FAM185A	156	Q8N0U4
STCIGSAIKSESGNS	CDKN2AIP	176	Q9NXV6
TAIATTSDCKRVISG	CFAP52	421	Q8N1V2
TGNTLKSGLCSALTT	MICU1	266	Q9BPX6
EVSSSLVCITGASGE	PLXNB1	1121	O43157
EKVTITCRASQSIGS	IGKV6D-21	36	A0A0A0MT36
KVTISCSGSSSNIGN	IGLV1-51	36	P01701
SLGKLTTGDACVSTS	PDZD2	1181	O15018
IGIAAGSSDKICTSS	EBLN2	191	Q6P2I7
ESGCKIQIASESSGI	FUBP3	106	Q96I24
VKCLNISETATSSLG	PRCP	341	P42785
SGNSCLSTSVTEDIK	KDM4C	451	Q9H3R0
TTSCDTKLQGAVCGV	MRC2	1231	Q9UBG0
STTGQLTSKATVGSC	LMNTD1	61	Q8N9Z9
LTSKATVGSCSRVEN	LMNTD1	66	Q8N9Z9
DVGAIVTCKVSSINS	EXOSC1	66	Q9Y3B2
ISITTGNKSISFAGC	OR2AP1	81	Q8NGE2
CEGDKTIVGSITNTN	CLPS	86	P04118
TIENTGTKQSTCSPG	ITPRID2	601	P28290
SVICVEGNIASGKTT	TK2	51	O00142
VSLTTNCSGKGILSG	IFT172	156	Q9UG01
ALVGSSGCGKSTTVQ	ABCB4	426	P21439
ALVGSSGCGKSTVVQ	ABCB4	1066	P21439
LSSSSKVRVEAVGCT	OBSCN	1666	Q5VST9
LSETKTISFSGCVTQ	OR4D9	86	Q8NGE8
ICSSAKGIVESSVTS	BOD1L1	1946	Q8NFC6
ACGEILTESTGTIQS	CUBN	931	O60494
DKSVCTLQITDTTGS	DIRAS1	51	O95057
KECVTTGRSSQGAVD	DYNC2H1	1516	Q8NCM8
SVICSDKTGTLTTNQ	ATP2A2	346	P16615
TGGITSSSTSKQVCV	KLHL15	431	Q96M94
QRSLSAKCVSGTGQV	CIBAR1	246	A1XBS5
GSSTSEKTLNICEVG	C6	901	P13671
TVTGDKDSVNLTCST	CEACAM1	336	P13688
AVPTGDASKCTVTVS	FLNA	1636	P21333
DKSICTLQITDTTGS	DIRAS2	51	Q96HU8
TVISGETGCGKTTQV	DHX36	226	Q9H2U1
ETGCGKTTQVTQFIL	DHX36	231	Q9H2U1
GSSSATCIISGNTVI	CR1L	131	Q2VPA4
GTNISETSLIGTAAC	SQLE	101	Q14534
GKKGDTVELTCTASQ	CD4	31	P01730
SSESGAVKRDCTITG	GHRHR	86	Q02643
KVSEGTTILLNCTGQ	IL7	106	P13232
TQSQKLTGSLGCSID	LYST	2116	Q99698
GKSSTIPSCGLQVSI	HASPIN	671	Q8TF76
KINSGSSLEAVTTCE	MARCHF7	591	Q9H992
TTASGTGLSEKTSVC	RNMT	36	O43148
CSVTVIGNSISSKGY	GRID1	756	Q9ULK0
SVCTTKTSTRIVGGT	KLKB1	381	P03952
GSFSETKSGVLCSLE	DCLRE1A	196	Q6PJP8
LLNAKGTVTSTATCV	DIP2A	1006	Q14689
VKSGSVTTKGSVCNI	CRB1	496	P82279
GLCKEGIAISDTTTT	SGK3	306	Q96BR1
CLEVTSISGKVQTAT	CD244	106	Q9BZW8
ETLGSTSVICSDKTG	ATP4A	376	P20648
TSVICSDKTGTLTQN	ATP4A	381	P20648
GTGVCSTRVKVFSSS	NHLRC1	286	Q6VVB1
GATTKESESKTCLGT	CNST	306	Q6PJW8
ISSLNGVSCEVGTET	COL6A6	1221	A6NMZ7
SEVSLKITGECSSSI	FOCAD	276	Q5VW36
SGTQAVSGSKDICIK	WDR77	136	Q9BQA1
LTGTKTISFAGCLTQ	OR1C1	86	Q15619
SSSLVEVRGSCVKSA	EPHA6	226	Q9UF33
FEGGKSTVNCSTTPV	NUP88	146	Q99567
GKALSTCSSGSTVVV	OR4A5	231	Q8NH83
LESKGSSVCQVTAIG	GPR137B	226	O60478
SKTVLTGTKDTVCSG	PLIN4	246	Q96Q06
TVLTGTKDTVCSGVT	PLIN4	281	Q96Q06
LTGTKDTVCSGVTGA	PLIN4	316	Q96Q06
KTVLTGTKNTVCSGV	PLIN4	346	Q96Q06
TQNIATGTKDTVCSG	PLIN4	411	Q96Q06
TKDTVCSGVTGAANV	PLIN4	451	Q96Q06
GTKDTVCSGVTSAVN	PLIN4	516	Q96Q06
TVLTGTKDAVCSGVT	PLIN4	776	Q96Q06
LTGTKDTVCSGVTGA	PLIN4	811	Q96Q06
SKTVLTGTKDTVCSG	PLIN4	906	Q96Q06
TGTKDTVCSGVTGAV	PLIN4	911	Q96Q06
EEGKTCFKQSLVTGT	ARHGAP20	751	Q9P2F6
EGIDVGTLLKSTCNT	PLEKHA8P1	31	O95397
TVAGCATSSKVVAAT	USH2A	3571	O75445
LGTTVCSKGSGEQQI	SUSD5	96	O60279
TCEIGTGILSLSNVS	RGS22	821	Q8NE09
NVVRSSSISGEICGS	RIMS3	16	Q9UJD0
TVTAVQKSEAGSGCG	OVCH1	406	Q7RTY7
STSVKLSTGCTGTLV	PRSS23	151	O95084
GSLVQQATDCSSTTK	SHROOM4	531	Q9ULL8
IKVVSGCQSSGISFQ	SLCO6A1	211	Q86UG4
ISTLSGVDLENGTCS	IARS2	351	Q9NSE4
EISVTSFTGCSVKQA	BRS3	381	P32247
AKVVGLSCTLATGST	CLCNKA	146	P51800
SGVKETVCFSDQITT	USP53	716	Q70EK8
CVATNGKEVVSSTGV	ROR1	131	Q01973
TCSGKTVLSPGFTEV	TOP3B	441	O95985
SGNSESTQKCGIDVT	TNFRSF11B	186	O00300
KESTGCHTQLSGVVT	SLC26A2	446	P50443
VGTSSKAEASVACSL	PTGIR	371	P43119
AEKLTGSCSVTQTGV	SELENON	96	Q9NZV5
GTCGTVVSTTNFIKA	FCMR	56	O60667
KGCTSVVTSESNIIR	ZNF292	2391	O60281
KSCLIVATTSGSESI	UBR1	991	Q8IWV7
ASVRTVNIGSTKGSC	SEMA7A	106	O75326
GKESISSCNTIESGI	GTF3C4	296	Q9UKN8
LLKVNGSTTAICATG	USP3	146	Q9Y6I4
SKTEEIKNVLGGSTC	ZGRF1	1236	Q86YA3
GTCLIVSSVKDSLTG	PHLPP1	566	O60346
VSTCETKELLNVGVS	TASOR2	1736	Q5VWN6
SGKQGICRLETSESS	ZNF407	86	Q9C0G0
TGKETFLSDCTVGGT	ZNF407	111	Q9C0G0
TCVEVASELGKSTNT	VEGFD	116	O43915
TKQLASLGCITTEGG	TRIM66	256	O15016
TDICLFSGSITQVGS	ZFYVE9	876	O95405
TVGTCKAATPTVVSA	YEATS2	1001	Q9ULM3
GGDVTLTCQTTTALF	NLRP14	386	Q86W24
LSKDQCIVISGESGS	MYO3B	426	Q8WXR4
CIVISGESGSGKTES	MYO3B	431	Q8WXR4